New combo therapy tested for rare blood disorder
NCT ID NCT07445893
Summary
This study is testing whether a new drug called gecacitinib, when combined with an existing medication (pegylated interferon), can help control polycythemia vera. Researchers want to see if this combination can bring blood counts back to normal levels and reduce symptoms like fatigue and itching. The study will involve about 30 adults with PV who haven't tried similar treatments before.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYCYTHEMIA VERA (PV) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.